Mr Thomas Reed Butaud, MD | |
4015 Hwy I 49 South Service Rd, Opelousas, LA 70570 | |
(337) 942-6503 | |
(337) 942-8831 |
Full Name | Mr Thomas Reed Butaud |
---|---|
Gender | Male |
Speciality | Orthopedic Surgery |
Experience | 42 Years |
Location | 4015 Hwy I 49 South Service Rd, Opelousas, Louisiana |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1447281001 | NPI | - | NPPES |
1321338 | Medicaid | LA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207X00000X | Orthopaedic Surgery | 14122 (Louisiana) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Opelousas General Health System | Opelousas, LA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Opelousas General Health System Physician Practices | 9830340694 | 45 |
News Archive
Petra Capital Partners, a private equity firm based in Nashville, Tennessee, today announced a $6 million investment in Superior Global Solutions ("SGS").
Dental hygiene has been a long practice of humans, stretching back to our ancient times, but that hasn't stop modern kids from disliking the daily routine. Many parents scramble new tricks in an effort to make the experience more attractive. Telling stories, buying musical toothbrushes, and singing songs are tactics parents use from their sleeves to spice up the process.
Pharmacyclics LLC today highlighted results from a sub-analysis of the Phase III RESONATE™ (PCYC-1112) trial, which found that previously-treated patients with chronic lymphocytic leukemia (CLL) who adhered to the recommended 420 mg dose of IMBRUVICA® (ibrutinib) experienced improved progression-free survival (PFS; the primary endpoint) as assessed by an Independent Review Committee (IRC), compared to patients who took lower doses or missed doses, regardless of high-risk genetic factors.
Contrary to earlier reports, a new study finds that stress does not appear to increase a person's risk of developing multiple sclerosis. The research is published in the May 31, 2011, print issue of Neurology, the medical journal of the American Academy of Neurology.
› Verified 3 days ago
Entity Name | Opelousas Orthopaedic Clinic |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1700964764 PECOS PAC ID: 2567473002 Enrollment ID: O20080428000039 |
News Archive
Petra Capital Partners, a private equity firm based in Nashville, Tennessee, today announced a $6 million investment in Superior Global Solutions ("SGS").
Dental hygiene has been a long practice of humans, stretching back to our ancient times, but that hasn't stop modern kids from disliking the daily routine. Many parents scramble new tricks in an effort to make the experience more attractive. Telling stories, buying musical toothbrushes, and singing songs are tactics parents use from their sleeves to spice up the process.
Pharmacyclics LLC today highlighted results from a sub-analysis of the Phase III RESONATE™ (PCYC-1112) trial, which found that previously-treated patients with chronic lymphocytic leukemia (CLL) who adhered to the recommended 420 mg dose of IMBRUVICA® (ibrutinib) experienced improved progression-free survival (PFS; the primary endpoint) as assessed by an Independent Review Committee (IRC), compared to patients who took lower doses or missed doses, regardless of high-risk genetic factors.
Contrary to earlier reports, a new study finds that stress does not appear to increase a person's risk of developing multiple sclerosis. The research is published in the May 31, 2011, print issue of Neurology, the medical journal of the American Academy of Neurology.
› Verified 3 days ago
Entity Name | Opelousas General Health System Physician Practices |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1295098747 PECOS PAC ID: 9830340694 Enrollment ID: O20121105000236 |
News Archive
Petra Capital Partners, a private equity firm based in Nashville, Tennessee, today announced a $6 million investment in Superior Global Solutions ("SGS").
Dental hygiene has been a long practice of humans, stretching back to our ancient times, but that hasn't stop modern kids from disliking the daily routine. Many parents scramble new tricks in an effort to make the experience more attractive. Telling stories, buying musical toothbrushes, and singing songs are tactics parents use from their sleeves to spice up the process.
Pharmacyclics LLC today highlighted results from a sub-analysis of the Phase III RESONATE™ (PCYC-1112) trial, which found that previously-treated patients with chronic lymphocytic leukemia (CLL) who adhered to the recommended 420 mg dose of IMBRUVICA® (ibrutinib) experienced improved progression-free survival (PFS; the primary endpoint) as assessed by an Independent Review Committee (IRC), compared to patients who took lower doses or missed doses, regardless of high-risk genetic factors.
Contrary to earlier reports, a new study finds that stress does not appear to increase a person's risk of developing multiple sclerosis. The research is published in the May 31, 2011, print issue of Neurology, the medical journal of the American Academy of Neurology.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Mr Thomas Reed Butaud, MD 4015 Hwy I 49 South Service Rd, Opelousas, LA 70570 Ph: (337) 942-6503 | Mr Thomas Reed Butaud, MD 4015 Hwy I 49 South Service Rd, Opelousas, LA 70570 Ph: (337) 942-6503 |
News Archive
Petra Capital Partners, a private equity firm based in Nashville, Tennessee, today announced a $6 million investment in Superior Global Solutions ("SGS").
Dental hygiene has been a long practice of humans, stretching back to our ancient times, but that hasn't stop modern kids from disliking the daily routine. Many parents scramble new tricks in an effort to make the experience more attractive. Telling stories, buying musical toothbrushes, and singing songs are tactics parents use from their sleeves to spice up the process.
Pharmacyclics LLC today highlighted results from a sub-analysis of the Phase III RESONATE™ (PCYC-1112) trial, which found that previously-treated patients with chronic lymphocytic leukemia (CLL) who adhered to the recommended 420 mg dose of IMBRUVICA® (ibrutinib) experienced improved progression-free survival (PFS; the primary endpoint) as assessed by an Independent Review Committee (IRC), compared to patients who took lower doses or missed doses, regardless of high-risk genetic factors.
Contrary to earlier reports, a new study finds that stress does not appear to increase a person's risk of developing multiple sclerosis. The research is published in the May 31, 2011, print issue of Neurology, the medical journal of the American Academy of Neurology.
› Verified 3 days ago
David B Clause, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4015 I 49 S Service Rd, Opelousas, LA 70570 Phone: 337-942-6503 Fax: 337-942-8831 | |
Mr. Gary L Porubsky, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4015 Hwy I-49 South Service Rd, Opelousas, LA 70570 Phone: 337-942-6503 Fax: 337-942-8831 | |
Dr. George Raymond Williams, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1233 Wayne Gilmore Circle, Suite 250-a, Opelousas, LA 70570 Phone: 337-948-8556 Fax: 337-948-6881 |